Table 2. Pooled hazard ratios for overall survival and recurrence-free survival.
Pooled analysis | Study number | HR (95% CI) | P for difference | P for heterogeneity and I-squared |
---|---|---|---|---|
Overall Survival | ||||
All groups | 15 | 0.853 (0.741-0.981) | 0.026 | 0.001 and 61.3% |
In colorectal cancer | 5 | 0.653 (0.430-0.991) | 0.045 | 0.038 and 60.6% |
In prostate cancer | 3 | 1.194 (0.735-1.941) | 0.474 | 0.085 and 59.5% |
Recurrence-free Survival | ||||
All groups | 19 | 0.846 (0.718-0.998) | 0.047 | 0.000 and 71.4% |
In prostate cancer | 7 | 0.919 (0.765-1.104) | 0.366 | 0.127 and 39.7% |
In ovarian cancer | 3 | 0.640 (0.396-1.033) | 0.068 | 0.133 and 50.4% |